This blog is called The Niche so publications on the stem cell niche often catch my eye even if that’s not something my own lab directly works on much. So today’s recommended reads will start with two papers on the stem cell niche. The first one focused on the niche gone wrong. The stem cell …
Recommend reads: stem cell niche, Georgia & FTC on clinics, more Read More »
Because of blogging here on The Niche and people giving me tips I often can see trends before they fully surface and a troubling new one is intranasal stem cell delivery by unproven clinics. Over the past year I have heard of many clinics now offering this approach. I’ve seen this in marketing and heard …
Clinics turning to potentially dangerous intranasal stem cell delivery Read More »
Let’s start off today’s recommended reads with the topic of life extension. No controversy there, right? This comes to mind because of a new preprint from BioViva, Liz Parrish, and George Church. I’m hoping to cover this on our Stem Cell Channel on YouTube. Gene therapy and life extension research The preprint is entitled, “New …
Weekly reads: life extension & BioViva, clinics & anti-vax, axolotls, systemic CRISPR Read More »
The International Society for Cell & Gene Therapy or ISCT held a really interesting webinar yesterday on the FDA and unproven stem cell clinics. It was focused on the expiration of the FDA’s discretionary period on unproven stem cell clinics. What will the FDA do now? The webinar included some ideas and also quite a …
New data on stem cell clinics, INDs, & more including from FDA itself Read More »
Stem cell clinics violating federal regulations have been a major problem for the FDA. Next month the FDA faces a historic moment on this problem. A grace period for clinics to become FDA compliant ends in May. Even so, it appears that hundreds of clinics will remain non-compliant after that. Some of the worst clinics …
Even in COVID times the FDA continues its stepped-up efforts against stem cell clinics and patients are suing clinics more too, which I cover in today’s post along with recommended stem cell research pubs. One of the papers at the top of my to-read list is on 3D chromatin in stem cells. FDA Warning Letter …
It’s encouraging to see that the states including now Arkansas via their attorney generals (or is it attorneys general?) are taking more action against stem cell clinic firms, but the big scope of AG action has somewhat surprised me. Arkansas AG suit The latest AG action on a stem cell clinic type firm comes from …
Arkansas adds to wave of state AG actions vs. stem cell clinics Read More »
In my view, it seems likely that the FDA has opened a big can of worms by starting to clear the COVID-19 trials and programs of for-profit stem cell clinics and other related firms. OK to Stemedica trial The FDA just approved another such effort, this one by the firm Stemedica. You can read more about …
FDA OK’s more COVID-19 efforts of unproven stem cell clinics Read More »
More states have taken action against stem cell clinic-related firms in the past year than ever before and now we can add Georgia to the list. Georgia adds to growing list of state AGs suing stem cell clinics The George Attorney General Chris Carr filed suit against several related firms (going by various names over …
The FTC has sharply increased its oversight activities against stem cell and regenerative clinic firms. These new actions include quite a few warning letters. Here is the FTC database for COVID-19-related warning letters. Note that recently the FTC added a new, helpful option to view all of its warning letters here. It’s a good source …
FTC fires off many warnings to stem cell clinics on COVID-19 Read More »